ARROWHEAD PHARMACEUTICALS, INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
ARWR on Nasdaq
Location
Pasadena, CA
Fiscal year end
30 September
Latest financial report
05 Feb 2026

Quick Takeaways

  • ARWR - ARROWHEAD PHARMACEUTICALS, INC. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 75%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-111%</span>.
  • Most recent SEC facts end date: 30 Jan 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-01-30) highlights Return On Equity 75.5%, Return On Assets 14.4%, and Operating Margin 15.5%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

75.5/100

Balanced Confidence medium

Return On Equity

75%

Metric score 100.0/100

Return On Assets

14%

Metric score 100.0/100

Financial Health

Current Ratio
3.38x
Quick Ratio
3.26x
Debt to Equity
1.24x

Strengths

Return On Equity, Return On Assets, and Revenues YoY

Watchpoints

No major risk flags from available metrics.

Key metrics snapshot

Return On Equity

75%

YoY: -111%

Industry median: -43% (n=675)

View history

Return On Assets

14%

YoY: -120%

Industry median: -47% (n=673)

View history

Operating Margin

15%

YoY: -100%

Industry median: -121% (n=298)

View history

Current Ratio

3.38x

YoY: -44%

Industry median: 3.39x (n=667)

View history

Quick Ratio

3.26x

YoY:

Industry median: 1.51x (n=289)

View history

Debt-to-equity

1.24x

YoY:

Industry median: 0.26x (n=530)

View history

Revenues YoY

43539%

YoY:

Industry median: 7.3% (n=302)

View history

Profitability

Metric Latest value YoY change
Return On Equity 76% -111%
Return On Assets 14% -120%
Operating Margin 15% -100%

Financial Health

Metric Latest value YoY change
Current Ratio 3.38x -44%
Quick Ratio 3.26x
Debt-to-equity 1.24x

Growth

Metric Latest value YoY change
Revenues YoY 43539%
Net Income (Loss) Attributable to Parent $202,265,000

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 140,032,190 +11%
Common Stock, Shares, Outstanding 137,391,000 +9.4%
Common Stock, Value, Issued $233,000 +6.9%
Weighted Average Number of Shares Outstanding, Basic 137,039,000 +9.8%
Weighted Average Number of Shares Outstanding, Diluted 140,706,000 +13%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $1,090,981,000 +43539%
Research and Development Expense $177,203,000 +29%
General and Administrative Expense $143,054,000 +40%
Operating Income (Loss) $300,567,000
Nonoperating Income (Expense) $45,648,000 -99%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $254,919,000
Income Tax Expense (Benefit) $29,000 -72%
Earnings Per Share, Basic 1.6
Earnings Per Share, Diluted 1.6
Accounts Receivable, after Allowance for Credit Loss, Current $218,871,000 +8655%
Other Assets, Current $22,855,000 +299%
Assets, Current $1,174,389,000 +106%
Property, Plant and Equipment, Net $378,584,000 -2.2%
Operating Lease, Right-of-Use Asset $43,361,000 -3.4%
Other Assets, Noncurrent $1,411,000 -54%
Assets $1,604,181,000 +58%
Accounts Payable, Current $32,937,000 +128%
Employee-related Liabilities, Current $14,270,000 +27%
Accrued Liabilities, Current $130,081,000 +119%
Contract with Customer, Liability, Current $111,933,000
Liabilities, Current $347,425,000 +271%
Contract with Customer, Liability, Noncurrent $53,825,000
Operating Lease, Liability, Noncurrent $102,129,000 -6.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,699,000 +62%
Retained Earnings (Accumulated Deficit) $1,596,343,000 +11%
Stockholders' Equity Attributable to Parent $568,422,000 +981%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $562,697,000 +903%
Liabilities and Equity $1,604,181,000 +58%
Share-based Payment Arrangement, Noncash Expense $19,371,000 +27%
Increase (Decrease) in Accounts Receivable $212,046,000 +8382%
Net Cash Provided by (Used in) Operating Activities $13,481,000
Net Cash Provided by (Used in) Financing Activities $14,750,000 -171%
Net Cash Provided by (Used in) Investing Activities $23,742,000 -131%
Common Stock, Shares Authorized 290,000,000 0%
Common Stock, Shares, Issued 140,052,000 +12%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $201,643,000 +274%
Operating Lease, Liability $109,658,000 -5.4%
Payments to Acquire Property, Plant, and Equipment $2,148,000 -71%
Lessee, Operating Lease, Liability, to be Paid $169,614,000 -8.2%
Property, Plant and Equipment, Gross $464,733,000 +3.3%
Operating Lease, Liability, Current $7,529,000 +15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $13,696,000 -8.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $15,050,000 -4.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $59,956,000 -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $13,985,000 +2.7%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,282,000 +2.7%
Operating Lease, Payments $15,577,000 +22%
Preferred Stock, Shares Outstanding 0
Amortization of Intangible Assets $1,700,000 0%
Depreciation, Depletion and Amortization $23,400,000 +31%
Share-based Payment Arrangement, Expense $60,263,000 -5.2%
Preferred Stock, Par or Stated Value Per Share 0.001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY